Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study shows how pneumococci challenge the immune system

Pneumococci are the most common cause of respiratory tract infections, such as otitis and sinusitis, as well as of severe infections like pneumonia and meningitis.

12 Nov 2018

Loyola tests new catheter ablation system that can reach deeper into heart muscle

Loyola Medicine is among two centers in the world offering a novel catheter ablation system intended to improve treatment outcomes for a life-threatening heart rhythm disorder called ventricular tachycardia.

9 Nov 2018

All infectious diseases likely to be seasonal

A new study has suggested that all infectious diseases are driven by seasonal elements, based on an analysis of 69 infectious diseases.

9 Nov 2018

Trumpeted new Medicare Advantage benefits will be hard for seniors to find

For some older adults, private Medicare Advantage plans next year will offer a host of new benefits, such as transportation to medical appointments, home-delivered meals, wheelchair ramps, bathroom grab bars or air conditioners for asthma sufferers.

9 Nov 2018

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

Globally, pneumonia and diarrhea together led to nearly one of every four deaths that occurred in children under five years of age in 2016.

9 Nov 2018

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

InDevR announced today that it will pursue proof of concept development for new VaxArray potency assays for measles and rubella vaccines sponsored by the Bill & Melinda Gates Foundation.

8 Nov 2018

Exploring why some athletes ice their muscles after exercise

We've all seen it, after a gruelling and physical rugby many athletes plunge themselves into a bath of icy cold water or even in a cold air chamber, a treatment known as cryotherapy.

8 Nov 2018

Persuading more health workers to have flu jab needs new approach

Persuading more health workers across the continent to have the flu jab to protect themselves and their patients cannot be done through facts and statistics alone, new research by a leading behavioral scientist from Kingston University in London has revealed.

7 Nov 2018

ECDC study estimates burden of infections caused by antibiotic-resistant bacteria

An ECDC study estimates the burden of five types of infections caused by antibiotic-resistant bacteria of public health concern in the European Union and in the European Economic Area.

6 Nov 2018

AI in medical space must be carefully tested for performance across wide range of populations

Artificial intelligence tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems, according to a study conducted at the Icahn School of Medicine at Mount and published in a special issue of PLOS Medicine on machine learning and health care.

6 Nov 2018

Cases of acute flaccid myelitis on the rise say federal health officials

The cases of acute flaccid myelitis (AFM) – a polio like debilitating illness affecting children is still on the rise announced the health officials from the Center for Disease Control and Prevention (CDC) this Monday (5th November 2018).

5 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Men with early prostate cancer choose lower survival odds to improve quality of life

Men who have been newly diagnosed with prostate cancer say they would trade some improvement in their odds of survival for improvements in side effects and quality of life, according to research presented at the 2018 NCRI Cancer Conference.

5 Nov 2018

Molecular virologist uses basic science to fight influenza

Molecular virologist Chad Petit, Ph.D., uses basic science to fight influenza -- through experiments at the atomic level.

3 Nov 2018

Cooling therapies may offer best protection against adverse effects of taxane-based chemotherapy

Due to their broad antitumor activity that inhibits the function of microtubules, taxanes are common chemotherapeutic agents utilized for the management of multiple cancer types from breast to prostate. Unfortunately, the frequency of their use is equally matched by the rates of expected and well known side effects.

2 Nov 2018

Four mild forms of adenovirus cases at Voorhees Pediatric Facility under control and no new cases reported

Voorhees Pediatric Facility, a pediatric special care nursing facility located in Voorhees, New Jersey, has had four patients with chronic lung disease contract a mild form of adenovirus.

2 Nov 2018

Measles can be deadly for people with weakened immune systems

Last year, a 26-year-old man receiving treatment for leukemia went to a Swiss hospital's emergency room with a fever, a sore throat, and a cough, and was admitted. His condition worsened, and 17 days later, he died from severe complications of measles.

1 Nov 2018

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.

1 Nov 2018

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Genentech, a member of the Roche Group , announced today that the randomized Phase III CLL14 study, which evaluated fixed-duration Venclexta® in combination with Gazyva® in people with previously untreated chronic lymphocytic leukemia and co-existing medical conditions, met its primary endpoint and showed a statistically significant reduction in the risk of disease worsening or death compared to standard-of-care Gazyva plus chlorambucil.

1 Nov 2018

New study to evaluate human immune system's response to influenza

The key to lasting protection against influenza may be in your bones. The cells that naturally protect you against illness originate and live in your bone marrow - and that is one spot where scientists will be looking to understand the human immune system's response to influenza in a groundbreaking new study led by the Human Vaccines Project.

1 Nov 2018

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Study shows how pneumococci challenge the immune system

Loyola tests new catheter ablation system that can reach deeper into heart muscle

All infectious diseases likely to be seasonal

Trumpeted new Medicare Advantage benefits will be hard for seniors to find

Report: Persistent inequities may hamper progress to stop child pneumonia and diarrhea deaths

InDevR's new VaxArray to improve potency testing for measles and rubella vaccines

Exploring why some athletes ice their muscles after exercise

Persuading more health workers to have flu jab needs new approach

ECDC study estimates burden of infections caused by antibiotic-resistant bacteria

AI in medical space must be carefully tested for performance across wide range of populations

Cases of acute flaccid myelitis on the rise say federal health officials

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Men with early prostate cancer choose lower survival odds to improve quality of life

Molecular virologist uses basic science to fight influenza

Cooling therapies may offer best protection against adverse effects of taxane-based chemotherapy

Four mild forms of adenovirus cases at Voorhees Pediatric Facility under control and no new cases reported

Measles can be deadly for people with weakened immune systems

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

New study to evaluate human immune system's response to influenza

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Newsletters you may be interested in